Transjugular intrahepatic porto-systemic shunt is a risk factor for liver dysplasia but not hepatocellular carcinoma: A retrospective study of explanted livers

被引:11
作者
Borentain, Patrick [1 ,2 ]
Garcia, Stephane [4 ]
Gregoire, Emilie [3 ]
Vidal, Vincent [5 ]
Ananian, Pascal [3 ]
Ressiot, Emmanuelle [1 ]
Hardwigsen, Jean [3 ]
Bartoli, Jean-Michel [5 ]
Moulin, Guy [5 ]
Botta-Fridlund, Danielle [1 ]
Le Treut, Yves Patrice [3 ]
Gerolami, Rene [1 ,2 ]
机构
[1] Hop Conception, Dept Hepatogastroenterol, F-13385 Marseille, France
[2] Univ Aix Marseille 2, UMR 911, Marseille, France
[3] Hop Conception, Dept Surg & Liver Transplantat, F-13385 Marseille, France
[4] Hop Nord Marseille, Dept Pathol, Marseille, France
[5] Hop La Timone, Dept Radiol, Marseille, France
关键词
Hepatocellular carcinoma; Large cell dysplasia; Liver transplantation; Small cell dysplasia; Transjugular portosystemic shunt; CELL DYSPLASIA; PORTOSYSTEMIC SHUNT; PREDICTIVE VALUE; VIRAL-HEPATITIS; CIRRHOSIS; TIPS; DIAGNOSIS; INCREASE;
D O I
10.1016/j.dld.2014.09.009
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Conflicting data exist regarding the risk for hepatocellular carcinoma after transjugular intrahepatic porto-systemic shunt (TIPS) insertion in cirrhotic patients. Methods: We retrospectively analysed histopathological data from 214 patients who were transplanted in our Institution including 68 patients who underwent TIPS placement before transplantation. Pathological lesions from explanted livers, including incidental hepatocellular carcinoma, small cell dysplasia and large cell dysplasia were recorded. Results: Pathological lesions were found in 36.4% of explanted livers. TIPS insertion was an independent risk factor for pathological lesion (HR = 2.11, p < 0.05), concurrently with age (HR = 1.10 per year, p < 0.001) and viral aetiology of cirrhosis (HR = 3.05, p < 0.001). When considering the different type of lesions, TIPS insertion was not associated with an increased risk for hepatocellular carcinoma but was an independent risk factor for liver dysplasia (HR = 2.15, p = 0.042). Conclusion: Although a direct relationship between TIPS insertion and hepatocellular carcinoma risk was not demonstrated in this study, the increased frequency of liver dysplasia observed in TIPS-bearing explanted livers deserves further prospective investigations with adequate follow-up. (C) 2014 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:57 / 61
页数:5
相关论文
共 24 条
  • [1] Patients with cirrhosis and bare-stent TIPS may have increased risk of hepatocellular carcinoma
    Bañares, R
    Núñez, O
    Escudero, M
    Fernández, C
    Vaquero, J
    Beceiro, I
    Echenagusía, A
    Clemente, G
    Santos, L
    [J]. HEPATOLOGY, 2005, 41 (03) : 566 - 571
  • [2] BJORNEBOE M, 1985, SCAND J GASTROENTERO, V20, P59
  • [3] LIVER-CELL DYSPLASIA IS A MAJOR RISK FACTOR FOR HEPATOCELLULAR-CARCINOMA IN CIRRHOSIS - A PROSPECTIVE-STUDY
    BORZIO, M
    BRUNO, S
    RONCALLI, M
    MELS, GC
    RAMELLA, G
    BORZIO, F
    LEANDRO, G
    SERVIDA, E
    PODDA, M
    [J]. GASTROENTEROLOGY, 1995, 108 (03) : 812 - 817
  • [4] Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension: Update 2009
    Boyer, Thomas D.
    Haskal, Ziv J.
    [J]. HEPATOLOGY, 2010, 51 (01) : 306 - 306
  • [5] Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
    Clavien, Pierre-Alain
    Lesurtel, Mickael
    Bossuyt, Patrick M. M.
    Gores, Gregory J.
    Langer, Bernard
    Perrier, Arnaud
    [J]. LANCET ONCOLOGY, 2012, 13 (01) : E11 - E22
  • [6] Hepatocellular carcinoma in cirrhotic patients with transjugular intrahepatic portosystemic shunt: A retrospective case-control study
    De Santis, Adriano
    Iegri, Claudia
    Kondili, Loreta
    Riggio, Oliviero
    Salvatori, Filippo Maria
    Catalano, Carlo
    Di Martino, Michele
    Bassanelli, Chiara
    Lupo, Marinella
    Lucatelli, Pierleone
    Attili, Adolfo Francesco
    [J]. DIGESTIVE AND LIVER DISEASE, 2014, 46 (08) : 726 - 730
  • [7] Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
    El-Serag, Hashem B.
    [J]. GASTROENTEROLOGY, 2012, 142 (06) : 1264 - +
  • [8] Elizalde J I, 1996, Gastroenterol Hepatol, V19, P189
  • [9] TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis:: A randomized controlled trial
    Escorsell, A
    Bañares, R
    García-Pagán, JC
    Gilabert, R
    Moitinho, E
    Piqueras, B
    Bru, C
    Echenagusia, A
    Granados, A
    Bosch, J
    [J]. HEPATOLOGY, 2002, 35 (02) : 385 - 392
  • [10] Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
    Fattovich, G
    Stroffolini, T
    Zagni, I
    Donato, F
    [J]. GASTROENTEROLOGY, 2004, 127 (05) : S35 - S50